Phase 2 study of preoperative chemotherapy with nab‐paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node‐positive pancreatic ductal adenocarcinoma

BACKGROUND: Neoadjuvant treatment with nab‐paclitaxel and gemcitabine for potentially operable pancreatic adenocarcinoma has not been well studied in a prospective interventional trial and could down‐stage tumors to achieve negative surgical margins. METHODS: A single‐arm, open‐label phase 2 trial (...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Emerson Y., Kardosh, Adel, Nabavizadeh, Nima, Foster, Bryan, Mayo, Skye C., Billingsley, Kevin G., Gilbert, Erin W., Lanciault, Christian, Grossberg, Aaron, Bensch, Kenneth G., Maynard, Erin, Anderson, Eric C., Sheppard, Brett C., Thomas, Charles R., Lopez, Charles D., Vaccaro, Gina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315770/
https://www.ncbi.nlm.nih.gov/pubmed/37132281
http://dx.doi.org/10.1002/cam4.5971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315770/
https://www.ncbi.nlm.nih.gov/pubmed/37132281
http://dx.doi.org/10.1002/cam4.5971

Ejemplares similares